Linking disease symptoms and subtypes with personalized systems-based phenotypes: A proof of concept study

Brain, Behavior, and Immunity

Volumn 26, Issue 7, 2012, Pages 1047-1056

  Aschbacher, Kirstin ^a,b   Adam, Emma K ^c   Crofford, Leslie J ^d   Kemeny, Margaret E ^a   Demitrack, Mark A ^e   Ben Zvi, Amos ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAMUELI INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e Neuronetics   (United States)

^f UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Chronic fatigue syndrome; Cortisol; Dynamical systems; Feedback sensitivity; Fsbromyalgia; Functional somatic disorders; Glucocorticoid resistance; Personalized medicine; Psychoneuroendocrinology; Sleep quality; Somatic symptoms; Stress arousal; Systems medicine

Indexed keywords

CORTICOTROPIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; COMORBIDITY; CONCEPT ANALYSIS; CONTROLLED STUDY; DYNAMICS; FEEDBACK SYSTEM; FEMALE; FIBROMYALGIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEUROENDOCRINE SYSTEM; PATHOPHYSIOLOGY; PHENOTYPE; PLASMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SLEEP QUALITY; SYMPTOM;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; ALGORITHMS; CIRCADIAN RHYTHM; DATA INTERPRETATION, STATISTICAL; DISEASE; FATIGUE SYNDROME, CHRONIC; FEMALE; FIBROMYALGIA; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INDIVIDUALIZED MEDICINE; MALE; MIDDLE AGED; MODELS, STATISTICAL; PHENOTYPE; PITUITARY-ADRENAL SYSTEM; YOUNG ADULT;

EID: 84865646270     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.06.002     Document Type: Article

References (64)

1. Aaron L.A., Burke M.M., Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch. Intern. Med. 2000, 160:221-227.
2. Adam E.K., Hawkley L.C., Kudielka B.M., Cacioppo J.T. Day-to-day dynamics of experience-cortisol associations in a population-based sample of older adults. Proc. Natl. Acad. Sci. USA 2006, 103:17058-17063.
3. Akaike H. New look at statistical-model identification. IEEE Trans. Autom. Control AC 1974, 19:716-723.
4. Alon U. An introduction to systems biology: design principles of biological circuits 2007, Chapman & Hall/CRC, Boca Raton, FL.
5. Anton H., Herr A. Calculus with Analytic Geometry 1995, Wiley, New York.
6. Backhaus J., Junghanns K., Hohagen F. Sleep disturbances are correlated with decreased morning awakening salivary cortisol. Psychoneuroendocrino 2004, 29:1184-1191.
7. Beck A.T., Steer R.A., Garbin M.G. Psychometric properties of the beck depression inventory - 25 years of evaluation. Clin. Psychol. Rev. 1988, 8:77-100.
8. Bigatti S.M., Hernandez A.M., Cronan T.A., Rand K.L. Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum. 2008, 59:961-967.
9. Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere M.B., Monauni T., Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23:57-63.
10. Boyce W.T., Ellis B.J. Biological sensitivity to context: I. An evolutionary-developmental theory of the origins and functions of stress reactivity. Dev. Psychopathol. 2005, 17:271-301.
11. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28:193-213.
12. Carlson J.M., Doyle J. Highly optimized tolerance: robustness and design in complex systems. Phys. Rev. Lett. 2000, 84:2529-2532.
13. Carlson N.E., Johnson T.D., Brown M.B. A Bayesian approach to modeling associations between pulsatile hormones. Biometrics 2009, 65:650-659.
14. Clow A., Hucklebridge F., Stalder T., Evans P., Thorn L. The cortisol awakening response: more than a measure of HPA axis function. Neurosci. Biobehav. Rev. 2010, 35:97-103.
15. Crofford L.J., Young E.A., Engleberg N.C., Korszun A., Brucksch C.B., McClure L.A., Brown M.B., Demitrack M.A. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav. Immun. 2004, 18:314-325.
16. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann. NY Acad. Sci. 2001, 933:222-234.
17. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 2007, 21:153-160.
18. Gaab J., Huster D., Peisen R., Engert V., Heitz V., Schad T., Schurmeyer T., Ehlert U. Assessment of cortisol response with low-dose and high-dose ACTH in patients with chronic fatigue syndrome and healthy comparison subjects. Psychosomatics 2003, 44:113-119.
19. Gaab J., Huster D., Peisen R., Engert V., Heitz V., Schad T., Schurmeyer T.H., Ehlert U. Hypothalamic-pituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological, and pharmacological stimulation. Psychosom. Med. 2002, 64:951-962.
20. Gaddam K., Pimenta E., Thomas S.J., Cofield S.S., Oparil S., Harding S.M., Calhoun D.A. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J. Hum. Hypertens. 2010, 24:532-537.
21. Gass P., Kretz O., Wolfer D.P., Berger S., Tronche F., Reichardt H.M., Kellendonk C., Lipp H.P., Schmid W., Schutz G. Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice. EMBO Rep. 2000, 1:447-451.
22. Geenen R., Bijlsma J.W. Deviations in the endocrine system and brain of patients with fibromyalgia: cause or consequence of pain and associated features?. Ann. NY Acad. Sci. 2010, 1193:98-110.
23. Gronfier C., Brandenberger G. Ultradian rhythms in pituitary and adrenal hormones: their relations to sleep. Sleep Med. Rev. 1998, 2:17-29.
24. Heim C., Nater U.M., Maloney E., Boneva R., Jones J.F., Reeves W.C. Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Arch. Gen. Psychiatry 2009, 66:72-80.
25. Hudson M., Cleare A.J. The 1microg short Synacthen test in chronic fatigue syndrome. Clin. Endocrinol. (Oxf.) 1999, 51:625-630.
26. Irwin M.R. Human psychoneuroimmunology: 20 years of discovery. Brain Behav. Immun. 2008, 22:129-139.
27. Irwin M.R., Cole S.W. Reciprocal regulation of the neural and innate immune systems. Nat. Rev. Immunol. 2011, 11:625-632.
28. Jacobson L. Hypothalamic-pituitary-adrenocortical axis regulation. Endocrinol. Metab. Clin. North Am. 2005, 34:271-292. vii.
29. Jason L.A., Unger E.R., Dimitrakoff J.D., Fagin A.P., Houghton M., Cook D.B., Marshall G.D., Klimas N., Snell C. Minimum data elements for research reports on CFS. Brain Behav. Immun. 2012, 26:401-406.
30. Jerjes W.K., Taylor N.F., Wood P.J., Cleare A.J. Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome. Psychoneuroendocrinology 2007, 32:192-198.
31. Kapsimalis F., Basta M., Varouchakis G., Gourgoulianis K., Vgontzas A., Kryger M. Cytokines and pathological sleep. Sleep Med. 2008, 9:603-614.
32. Kato K., Sullivan P.F., Evengard B., Pedersen N.L. A population-based twin study of functional somatic syndromes. Psychol. Med. 2009, 39:497-505.
33. Katon W., Russo J. Chronic fatigue syndrome criteria. A critique of the requirement for multiple physical complaints. Arch. Intern. Med. 1992, 152:1604-1609.
34. Kitano H. Towards a theory of biological robustness. Mol. Syst. Biol. 2007, 3.
35. Krueger J.M. The role of cytokines in sleep regulation. Curr. Pharm. Des. 2008, 14:3408-3416.
36. Lentjes E.G., Griep E.N., Boersma J.W., Romijn F.P., de Kloet E.R. Glucocorticoid receptors, fibromyalgia and low back pain. Psychoneuroendocrino 1997, 22:603-614.
37. Lupien S.J., de Leon M., de Santi S., Convit A., Tarshish C., Nair N.P., Thakur M., McEwen B.S., Hauger R.L., Meaney M.J. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat. Neurosci. 1998, 1:69-73.
38. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
39. McCain G.A., Tilbe K.S. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J. Rheumatol. Suppl. 1989, 19:154-157.
40. Miller G.E., Chen E., Zhou E.S. If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol. Bull. 2007, 133:25-45.
41. Moldofsky H. Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome. Adv. Neuroimmunol. 1995, 5:39-56.
42. Moshiree B., Price D.D., Robinson M.E., Gaible R., Verne G.N. Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia. Clin. J. Pain 2007, 23:323-330.
43. National Research Council Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease 2011, National Academies Press, Washington, DC.
44. Pace T.W., Hu F., Miller A.H. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav. Immun. 2007, 21:9-19.
45. Patarca-Montero R., Antoni M., Fletcher M.A., Klimas N.G. Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl. Neuropsychol. 2001, 8:51-64.
46. Pennebaker J.W. The Psychology of Physical Symptoms 1982, Springer, New York.
47. Rowe P.C., Calkins H., DeBusk K., McKenzie R., Anand R., Sharma G., Cuccherini B.A., Soto N., Hohman P., Snader S., Lucas K.E., Wolff M., Straus S.E. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA 2001, 285:52-59.
48. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 2000, 57:925-935.
49. Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 2000, 21:55-89.
50. Scott L.V., Medbak S., Dinan T.G. Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr. Scand. 1998, 97:450-457.
51. Scott L.V., Medbak S., Dinan T.G. The low dose ACTH test in chronic fatigue syndrome and in health. Clin. Endocrinol. (Oxf.) 1998, 48:733-737.
52. Seborg D.E., Edgar T.F., Mellichamp D. Process Dynamics and Control 2004, Springer.
53. Sephton S.E., Sapolsky R.M., Kraemer H.C., Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer I 2000, 92:994-1000.
54. Sriram K., Rodriguez-Fernandez M., Doyle F.J. Modeling Cortisol Dynamics in the Neuro-endocrine Axis Distinguishes Normal, Depression, and Post-traumatic Stress Disorder (PTSD) in Humans. PLoS Comput. Biol. 2012, 8:e1002379.
55. Sterling P. Allostasis: a model of predictive regulation 2011, Physiol Behav.
56. Tanriverdi F., Karaca Z., Unluhizarci K., Kelestimur F. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress 2007, 10:13-25.
57. Theorell T., Blomkvist V., Lindh G., Evengard B. Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis. Psychosom. Med. 1999, 61:304-310.
58. Van Cauter E., Leproult R., Plat L. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA 2000, 284:861-868.
59. Van Den Eede F., Moorkens G., Van Houdenhove B., Cosyns P., Claes S.J. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. Neuropsychobiology 2007, 55:112-120.
60. Walker J.J., Terry J.R., Lightman S.L. Origin of ultradian pulsatility in the hypothalamic-pituitary-adrenal axis. Proc Biol Sci 2010, 277:1627-1633.
61. Weston A.D., Hood L. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J. Proteome Res. 2004, 3:179-196.
62. Wingenfeld K., Nutzinger D., Kauth J., Hellhammer D.H., Lautenbacher S. Salivary cortisol release and hypothalamic pituitary adrenal axis feedback sensitivity in fibromyalgia is associated with depression but not with pain. J. Pain 2010, 11:1195-1202.
63. Young E.A., Carlson N.E., Brown M.B. Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology 2001, 25:267-276.
64. Zeiders K.H., Doane L.D., Adam E.K. Reciprocal relations between objectively measured sleep patterns and diurnal cortisol rhythms in late adolescence. J. Adolesc. Health 2011, 48:566-571.